{"id":10939,"date":"2020-01-09T16:36:32","date_gmt":"2020-01-09T15:36:32","guid":{"rendered":"https:\/\/udic.es\/?p=10939"},"modified":"2020-01-09T16:36:32","modified_gmt":"2020-01-09T15:36:32","slug":"our-clinical-trials-unit-remains-in-prominent-position","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/","title":{"rendered":"Our clinical trials unit remains in prominent position"},"content":{"rendered":"<p>We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks in Parkinson.<\/p>\n<p>We are also leading the national inclusion of patients in the Clarity AD trial (monoclonal anti-amyloid antibody in early Alzheimer)<\/p>\n<p>Finally, in the Graduate trial (monoclonal subcutaneous in Alzheimer) we are the second recruitment site in our country.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks in Parkinson. We are also leading the national inclusion of patients in the Clarity AD trial (monoclonal anti-amyloid antibody in early Alzheimer) Finally, in the Graduate trial (monoclonal subcutaneous in Alzheimer)&#8230;<\/p>\n","protected":false},"author":4,"featured_media":9567,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[132,135,130],"tags":[],"class_list":["post-10939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzeimer-en","category-news","category-parkinson-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-09T15:36:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1156\" \/>\n\t<meta property=\"og:image:height\" content=\"762\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"SUSANA ANDRADE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SUSANA ANDRADE\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\"},\"author\":{\"name\":\"SUSANA ANDRADE\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\"},\"headline\":\"Our clinical trials unit remains in prominent position\",\"datePublished\":\"2020-01-09T15:36:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\"},\"wordCount\":71,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg\",\"articleSection\":[\"Alzeimer\",\"News\",\"Parkinson\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\",\"url\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\",\"name\":\"Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg\",\"datePublished\":\"2020-01-09T15:36:32+00:00\",\"description\":\"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg\",\"width\":1156,\"height\":762,\"caption\":\"laboralsUDIC6\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our clinical trials unit remains in prominent position\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03\",\"name\":\"SUSANA ANDRADE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g\",\"caption\":\"SUSANA ANDRADE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/","og_locale":"en_US","og_type":"article","og_title":"Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","og_description":"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks","og_url":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/","og_site_name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2020-01-09T15:36:32+00:00","og_image":[{"width":1156,"height":762,"url":"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg","type":"image\/jpeg"}],"author":"SUSANA ANDRADE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SUSANA ANDRADE"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#article","isPartOf":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/"},"author":{"name":"SUSANA ANDRADE","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03"},"headline":"Our clinical trials unit remains in prominent position","datePublished":"2020-01-09T15:36:32+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/"},"wordCount":71,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg","articleSection":["Alzeimer","News","Parkinson"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/","url":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/","name":"Our clinical trials unit remains in prominent position - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg","datePublished":"2020-01-09T15:36:32+00:00","description":"We have reached the first position, in December 2019, in the international inclusion of patients in the trial with sublingual apomorphine and motor blocks","breadcrumb":{"@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2018\/11\/laboralsUDIC6.jpg","width":1156,"height":762,"caption":"laboralsUDIC6"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/our-clinical-trials-unit-remains-in-prominent-position\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"Our clinical trials unit remains in prominent position"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/7b598050df55fbeadbf6cdc699c31c03","name":"SUSANA ANDRADE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae155cf03dc49fd596e9750d3cfd63ee?s=96&d=mm&r=g","caption":"SUSANA ANDRADE"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=10939"}],"version-history":[{"count":0,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10939\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media\/9567"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=10939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/categories?post=10939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/tags?post=10939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}